Predict your next investment

Angel Investor (Group)
savannahangelpartners.com

See what CB Insights has to offer

Investments

39

Portfolio Exits

7

About Ariel Savannah Angel Partners

Ariel Savannah Angel Partners (ASAP) is a member-driven angel investment group which invests in early-stage high-growth potential companies. ASAP members are accredited individual investors who actively participate in reviewing investment opportunities and work on member teams to conduct due diligence on selected opportunities. The group invests primarily in Georgia, South Carolina and the Southeast region.

Ariel Savannah Angel Partners Headquarters Location

Savannah, Georgia,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Ariel Savannah Angel Partners News

Mill It Snares $765K Seed Funding

May 10, 2021

Kern Venture Group led a $765,000 Series Seed round for Mill It. Ariel Savannah Angel Partners, alongside investors from the Santa Barbara Angel Alliance and Tech Coast Angels, filled out the remainder of the round. Mill It is a plant-based company that makes dairy alternative products by using ancient grains. Through a proprietary fermentation method, Mill It has developed the first plant-based buttermilk which it plans to use to create several new plant-based products and offerings including its salad dressings. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Ariel Savannah Angel Partners Investments

39 Investments

Ariel Savannah Angel Partners has made 39 investments. Their latest investment was in New View Surgical as part of their Series B on September 9, 2021.

CBI Logo

Ariel Savannah Angel Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/16/2021

Series B

New View Surgical

$9M

Yes

2

9/8/2015

Unattributed VC - III

Cognition Therapeutics

$12M

Yes

1

12/20/2013

Bridge

Avaxia Biologics

$2.87M

No

1

6/7/2013

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

5/2/2013

Angel - IV

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/16/2021

9/8/2015

12/20/2013

6/7/2013

5/2/2013

Round

Series B

Unattributed VC - III

Bridge

Series B - II

Angel - IV

Company

New View Surgical

Cognition Therapeutics

Avaxia Biologics

Subscribe to see more

Subscribe to see more

Amount

$9M

$12M

$2.87M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

0

Ariel Savannah Angel Partners Portfolio Exits

7 Portfolio Exits

Ariel Savannah Angel Partners has 7 portfolio exits. Their latest portfolio exit was Respiratory Motion on June 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/1/2022

Acquired

$99M

3

10/8/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

4/28/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/15/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/12/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/1/2022

10/8/2021

4/28/2021

5/15/2019

10/12/2017

Exit

Acquired

IPO

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.